ABA-independent activation of CRC by VP1::LEC2-B3 and VP1::FUS3-B3 increased with transgene expression (Figure 3B, D) reaching maximum levels of CRC expression that were one to two log units lower than obtained in ABA treated seedlings (Figure 3F). This evidence concerns the gene ADGRL1 and colorectal carcinoma.